Find clinical trials for Lung Cancer in Durham, NC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lung Cancer trials near Durham, NC, USA:
The purpose of this study is to determine whether availability of DNA Evaluation of Fragments for Early Interception (DELFI) Lung Cancer...
Durham, North Carolina, United States
a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...
Phase 2
Chapel Hill, North Carolina, United States and 43 other locations
The main aim of this study is to:evaluate safety and efficacy (per Response Evaluation Criteria in Solid Tumors version 1.1 [RECIST 1.1] by investiga...
Phase 2
Durham, North Carolina, United States and 79 other locations
study was designed to compare the efficacy and safety of I-DXd with treatment of physician's choice in participants with relapsed small cell lung...
Phase 3
Durham, North Carolina, United States of America and 198 other locations
in patients with BRAFV600E-mutant metastatic non-small cell lung cancer (NSCLC). Patients who are either treatment-naïve, OR who ha...
Phase 2
Durham, North Carolina, United States and 157 other locations
results observed in participants with Extensive-stage Small Cell Lung Cancer (ES-SCLC) who received at least 1 prior line of platin...
Phase 2
Durham, North Carolina, United States and 100 other locations
This is a Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab or Durvalumab and Tremelimumab as...
Phase 3
Chapel Hill, North Carolina, United States and 181 other locations
overall response rate (ORR) when compared to nivolumab plus PDCT in participants with previously untreated Stage IV or recurrent non-small cell lung...
Phase 2
Durham, North Carolina, United States and 126 other locations
survival compared with carboplatin, etoposide, and nivolumab alone in newly diagnosed participants with extensive-stage small cell lung cancer...
Phase 2
Durham, North Carolina, United States and 42 other locations
and anti-PD1 therapy for subjects with refractory non-small cell lung cancer.The purpose of this study is to:Test the safety and ab...
Phase 1
Raleigh, North Carolina, United States
Clinical trials
Research sites
Resources
Legal